NEXUS BIOPHARMA INC Cashflow Statement

Ask AI

Financial Statements

In USD, except per-share amounts

	FY2017 12 months to Feb 28, 2017	FY2016 12 months to Dec 31, 2015	FY2015 12 months to Dec 31, 2014	FY2014 12 months to Dec 31, 2013	FY2013 12 months to Dec 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Forgiveness of debt income
Capital contributions: expenses paid by Officers
Expenses paid by officers
Prepaid expense
Accounts payable
Adjustments to reconcile net loss to net cash used by operating activities
Amortization of debt discount
Depreciation and Amortization expense
Stock based compensation
Change in operating assets and liabilities
Prepaid rent
Accounts payable - related parties
Accounts payable and accrued expenses
NET CASH USED IN OPERATING ACTIVITIES

CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for furniture and equipment
Cash paid for website development costs
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable
Proceeds from equity line of credit
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET DECREASE IN CASH
Cash at the beginning of the period
Cash at the end of the period
NON CASH TRANSACTIONS
Cancellation of shares
Adjustment due to reverse merger

Comments